Ceftriaxon versus ampicillin therapy for purulent meningitis in adults

P. Narciso, P. De Mori, R. Giannuzzi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Ten adult patients suffering from purulent meningitis were randomly treated with Rocephin (active ingredient ceftriaxon) or ampicillin. All the pathogens were sensitive to the agents used. All the patients were cured. In the patients treated with Rocephin, the parameters of the ESR and the halving time of the number of CSF cells returned to normal sooner than in the patients treated with ampicillin. Two patients in each group were in coma: the median awakening time was shorter in those in the Rocephin group than in patients in the other group. The authors are of the opinion that Rocephin, administered in a dose of 22-50 mg/kg bodyweight twice daily, provides a good alternative to ampicillin because of its outstanding penetration into the CSF and its high level of antimicrobial activity. It is especially indicated when the pathogens involved are resistant to other standard agents.

Original languageEnglish
Pages (from-to)717-719
Number of pages3
JournalDrugs under Experimental and Clinical Research
Volume9
Issue number10
Publication statusPublished - 1983

Fingerprint

Ceftriaxone
Ampicillin
Meningitis
Therapeutics
Coma
Cell Count

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

Ceftriaxon versus ampicillin therapy for purulent meningitis in adults. / Narciso, P.; De Mori, P.; Giannuzzi, R.

In: Drugs under Experimental and Clinical Research, Vol. 9, No. 10, 1983, p. 717-719.

Research output: Contribution to journalArticle

Narciso, P, De Mori, P & Giannuzzi, R 1983, 'Ceftriaxon versus ampicillin therapy for purulent meningitis in adults', Drugs under Experimental and Clinical Research, vol. 9, no. 10, pp. 717-719.
Narciso, P. ; De Mori, P. ; Giannuzzi, R. / Ceftriaxon versus ampicillin therapy for purulent meningitis in adults. In: Drugs under Experimental and Clinical Research. 1983 ; Vol. 9, No. 10. pp. 717-719.
@article{62c8a86c4011443b8a97b087fcf69040,
title = "Ceftriaxon versus ampicillin therapy for purulent meningitis in adults",
abstract = "Ten adult patients suffering from purulent meningitis were randomly treated with Rocephin (active ingredient ceftriaxon) or ampicillin. All the pathogens were sensitive to the agents used. All the patients were cured. In the patients treated with Rocephin, the parameters of the ESR and the halving time of the number of CSF cells returned to normal sooner than in the patients treated with ampicillin. Two patients in each group were in coma: the median awakening time was shorter in those in the Rocephin group than in patients in the other group. The authors are of the opinion that Rocephin, administered in a dose of 22-50 mg/kg bodyweight twice daily, provides a good alternative to ampicillin because of its outstanding penetration into the CSF and its high level of antimicrobial activity. It is especially indicated when the pathogens involved are resistant to other standard agents.",
author = "P. Narciso and {De Mori}, P. and R. Giannuzzi",
year = "1983",
language = "English",
volume = "9",
pages = "717--719",
journal = "Drugs under Experimental and Clinical Research",
issn = "0378-6501",
publisher = "Bioscience Ediprint Inc.",
number = "10",

}

TY - JOUR

T1 - Ceftriaxon versus ampicillin therapy for purulent meningitis in adults

AU - Narciso, P.

AU - De Mori, P.

AU - Giannuzzi, R.

PY - 1983

Y1 - 1983

N2 - Ten adult patients suffering from purulent meningitis were randomly treated with Rocephin (active ingredient ceftriaxon) or ampicillin. All the pathogens were sensitive to the agents used. All the patients were cured. In the patients treated with Rocephin, the parameters of the ESR and the halving time of the number of CSF cells returned to normal sooner than in the patients treated with ampicillin. Two patients in each group were in coma: the median awakening time was shorter in those in the Rocephin group than in patients in the other group. The authors are of the opinion that Rocephin, administered in a dose of 22-50 mg/kg bodyweight twice daily, provides a good alternative to ampicillin because of its outstanding penetration into the CSF and its high level of antimicrobial activity. It is especially indicated when the pathogens involved are resistant to other standard agents.

AB - Ten adult patients suffering from purulent meningitis were randomly treated with Rocephin (active ingredient ceftriaxon) or ampicillin. All the pathogens were sensitive to the agents used. All the patients were cured. In the patients treated with Rocephin, the parameters of the ESR and the halving time of the number of CSF cells returned to normal sooner than in the patients treated with ampicillin. Two patients in each group were in coma: the median awakening time was shorter in those in the Rocephin group than in patients in the other group. The authors are of the opinion that Rocephin, administered in a dose of 22-50 mg/kg bodyweight twice daily, provides a good alternative to ampicillin because of its outstanding penetration into the CSF and its high level of antimicrobial activity. It is especially indicated when the pathogens involved are resistant to other standard agents.

UR - http://www.scopus.com/inward/record.url?scp=0021025520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021025520&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 717

EP - 719

JO - Drugs under Experimental and Clinical Research

JF - Drugs under Experimental and Clinical Research

SN - 0378-6501

IS - 10

ER -